Health Care: Drugs

Synthetic Biologics Inc (SYN: AMEX)

$1.78 n/a | n/a%
09/30/14 - 04:01 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 0.00 0.00 0.00 3.16M
Cost of Sales 0.00 0.00 0.00 108.92K
Gross Operating Profit 0.00 0.00 0.00 3.06M
Selling, General, and Administrative Expenses 5.83M 5.01M 2.59M 2.70M
Research & Development 6.51M 12.29M 3.34M 1.58M
Operating Income before D & A (EBITDA) -12.34M -17.30M -5.93M -1.23M
Depreciation & Amortization 43.00K 63.00K 201.00K 358.71K
Interest Income 33.00K 33.00K 14.00K 413.00
Other Income - Net -12.00K -18.00K -1.71M -117.51K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -12.36M -17.35M -7.83M -1.70M
Interest Expense 0.00 0.00 0.00 10.11K
Pre-Tax Income -12.36M -17.35M -7.83M -1.71M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -1.00K 0.00 0.00 0.00
Net Income From Continuing Operations -12.32M -17.28M -7.63M -1.71M
Net Income From Discontinued Operations 0.00 216.00K -523.00K 0.00
Net Income From Total Operations -12.32M -17.07M -8.15M -1.71M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -12.32M -17.07M -8.15M -1.71M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-12.32M -17.28M -7.63M -1.71M
Preferred Dividends
Net Income Available To Common -12.32M -17.28M -7.63M -1.71M
Basic EPS from Continuing Ops. -0.27 -0.50 -0.27 -0.08
Basic EPS from Discontinued Ops. 0.00 0.01 -0.02 0.00
Basic EPS from Total Operations -0.27 -0.49 -0.29 -0.08
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.27 -0.49 -0.29 -0.08
Basic Normalized Net Income/Share -0.27 -0.50 -0.27 -0.08
EPS fr Continuing Ops. -0.27 -0.50 -0.27 -0.08
EPS fr Discontinued Ops 0.00 0.01 -0.02 0.00
EPS fr Total Ops. -0.27 -0.49 -0.29 -0.08
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.27 -0.49 -0.29 -0.08
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.27 -0.50 -0.27 -0.08
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SYN

Latest SYN Headlines from TheStreet

More Financial News for SYN

Press Releases for SYN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter